Hostname: page-component-857557d7f7-nfgnx Total loading time: 0.001 Render date: 2025-12-03T06:07:50.658Z Has data issue: false hasContentIssue false

Fluoxetine–terfenadine and sexual dysfunction

Published online by Cambridge University Press:  03 January 2018

A. Valmana
Affiliation:
Department of Psychiatry, St George's Hospital Medical School, Cranmer Terrace, London SWI7 0RE
P. Purcell
Affiliation:
Haleacre Unit, Amersham Hospital, Whielden Street, Amersham, Bucks HP7 0JD
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Columns
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

Alzenberg, D., Zamishlany, Z. & Weizman, A. (1995) Cyproheptadine treatment of sexual dysfunction induced by SSRI. Clinical Neuropharmacology, 18, 320324.CrossRefGoogle Scholar
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.Google Scholar
Labatte, L. A. & Pollack, M. H. (1994) Treatment of fluoxetine induced sexual dysfunction with bupropion: a case report. Annals of Clinical Psychiatry, 6, 1315.CrossRefGoogle Scholar
Marchiando, R. J., Cook, M. D. & Jue, S. G. (1995) Probable terfenadine–fluoxetine associated cardiac toxicity (letter). Annals of Pharmacotherapy, 29, 937938.CrossRefGoogle Scholar
Nemeroff, C. B., DaVane, C. L. & Pollock, B. G. (1996) Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry, 153, 311320.Google Scholar

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.